神經調節設備市場：依細分市場劃分的規模、佔有率、法規、償付、程序、到2033年的預測

神經調節器是透過調節神經系統活動來治療各種神經和精神疾病的醫療器材。神經調節劑透過向神經系統的目標區域提供電或磁刺激來發揮作用。它為神經和精神疾病（例如藥物和手術）的傳統治療提供了替代方案。深部腦部刺激器（DBS）、胃電刺激器（GES）、導極、薦神經刺激器（SNS）、脊髓刺激器（SCS）、週邊神經刺激器（PNS）、迷走神經刺激器（VNS）等包含在此類別中。

由於神經系統疾病的高盛行率影響著人口老化，這龐大的老年人口基數是神經調節市場的主要驅動力。

本報告深入探討了全球神經調節劑市場，包括競爭格局、SWOT 分析、到2033年的市場預測以及區域和國家趨勢。

目錄

目前已上市的神經調節劑及競爭狀況

• 對主要產業趨勢的見解
• 2015年至2033年神經調節劑各細分市場的市場總收入與市場前景
• 有關單位數量、平均售價和市場價值的詳細資料

全球、區域與國家見解

• 神經調節劑市場的 SWOT 分析
• 神經調節劑市場的競爭動態洞察與趨勢
• 各國醫療保健系統概覽
• 依國家/地區劃分的償付政策
• 各國醫療科技的監管狀況

Neuromodulation Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative and qualitative market trends within Neurology Devices therapeutic area.

Neuromodulation devices are medical devices that are used to treat various neurological and psychiatric disorders by modulating the activity of the nervous system. Neuromodulation Devices work by delivering electrical or magnetic stimulation to targeted areas of the nervous system. Neuromodulation devices offer an alternative to traditional treatments for neurological and psychiatric disorders, such as medications and surgery. Deep brain stimulators (DBS), gastric electric stimulators (GES), leads, sacral nerve stimulators (SNS), spinal cord stimulators (SCS), peripheral nerve stimulators (PNS) and vagus nerve stimulators (VNS) are the segments covered under this category.

Due to the large prevalence of neurological conditions impacting the aging population, this huge geriatric population base is a large driver of the neuromodulation market.

Each of the covered 39 countries color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Neuromodulation Devices and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total Neuromodulation Devices market revenue by segment and market outlooks from 2015-2033.
• Market level data on units, average selling prices and market values.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Neuromodulation Devices market.
• Competitive dynamics insights and trends provided for Neuromodulation Devices market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered - Medtronic Plc, Abbott Laboratories, Boston Scientific Corp, LivaNova Plc, Nevro Corp, AirLife, Beijing Pins Medical Co Ltd, Curonix LLC, Laborie Medical Technologies Inc, Bioness Inc, Avanos Medical Inc, IntraPace Inc, B. Braun Melsungen AG, Axonics Inc, NeuroPace Inc, Xavant Technology (Pty) Ltd, ReShape Lifesciences Inc and Others

Countries covered - United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Neuromodulation Devices marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
• Develop business strategies by understanding the trends shaping and driving Neuromodulation Devices market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Neuromodulation Devices market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Neuromodulation Devices market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.